Gutiérrez-Rojas L

Psychiatry, Hospital Universitario Clínico San Cecilio, Andalusian Health Service (SAS), Granada ,

7 papers · ORCID

ArticleKetamine

Care Next Door: Community Outpatient Esketamine Across Urban and Rural Clinics

García Jiménez J, Posik S, Herrejón B +1

Europe PMC2026
ArticleKetamine

Intranasal Esketamine for Treatment-Resistant Depression in Real-World Multicenter Practice: Clinical Effectiveness, Functional Recovery, and Patient-Reported Quality of Life

De Santiago-Diaz A, Arostegui-Uranga S, Pérez-Poza A +7

Europe PMC2026
ArticleKetamine

Early Treatment and Functional Recovery in Treatment-Resistant Depression: Real-World Evidence from Intranasal Esketamine in Spain

De Santiago-Diaz A, Madrazo-Maza M, Pavón-Navajas C +14

Europe PMC2026
ArticleKetamine

Clinical guidance on the use of esketamine nasal spray for patients with treatment resistant depression: A European Delphi consensus report.

Young AH, Baune BT, Benatti B +13

Europe PMC2026
ArticleKetamine

Esketamine nasal spray for treatment-resistant depression: A retrospective multicenter real-world cohort study on effectiveness and suicidal outcomes.

García-Jiménez J, Nuñez-Arias D, Carretero Merelo G +4

Europe PMC2026
ArticleKetamine

Treatment-resistant depression and intranasal esketamine: Spanish consensus on theoretical aspects.

Mora F, Ramos-Quiroga JA, Baca-García E +7

Europe PMC2025
ArticleKetamine

Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatment.

Gutiérrez-Rojas L, Vendrell-Serres J, Ramos-Quiroga JA +10

Europe PMC2025